Latest news for Impedimed (OTC:IPDQF) Stock

Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognizes revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.

News

Intraday Update

Markets

Movers

Trading Ideas

ABEV

ABIO

ABMD

ABVC

ACCYY

ACHV

ACIW

ACOR

ACRFF

ACRX

ACSAY

ACST

ADHC

ADMA

ADMP

AEGOF

AFLYY

AFRAF

AGCO

AGEEF

AHKSY

AHOTF

AIBGY

AIPUY

AKRX

ALDX

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

ALLY

ALMFF

ALOT

ALSN

ALTM

ALXN

AMADY

AMCX

AMKBF

AMKBY

AMNP

AMPH

AMRH

AMRQQ

AMTX

ANAT

ANCN

ANGO

ANIP

ANZLY

APEX

APHA

APLE

APTS

AQARF

ARCB

ARCH

ARGGY

ARGO

ARLP

ARNA

ARNGF

AROC

ARREF

ARTL

ASNA

ASTVF

ATRA

ATRI

ATROB

ATSG

ATUSF

AUTL

Stocks That Hit 52-Week Lows On Thursday

ALXEF

BRGGF

CCRGF

CDGXF

CEIX

CWBHF

DDMX

DRRSF

ECOR

ELGX

EMERALD HEALTH THERAPUTCS by Emerald Health Therapeutics Inc.

EMHTF

FEWP

FLWPF

FNGR

GAXY

GAYGF

GCAN

GFTX

GGBXF

GLBS

GNMK

GPOR

GSUM

HAPP

HESG

HRVOF

IDGBF

INDXF

INND

IPDQF

KAYS

KRKR

MFCSF

MJNE

MMNFF

MODERN CINEMA GROUP INC by Modern Cinema Group, Inc.

MOCI

MRAM

MTTWF

NAKD

NOSUF

OWPC

OWRDF

PACB

PDSB

PFGTF

PHIO

PROS

RDDTF

REPO

RNLSY

ROSE

RYDBF

RYPPF

SEEK

SEXHF

SINT

SNDL

SNNVF

SPRWF

SPSTF

STGPF

STWC

TGIFF

TNXP

TSRYY

TUWOY

VBIX

VLRX

XERS

YAYO

VRSRF

SPOI

AZIL

Stocks That Hit 52-Week Lows On Tuesday

Impedimed Ltd

Impedimed Limited (AU:IPD) has released an update. ImpediMed Limited has announced a significant increase in the interest holdings of Dr. Parmjot B...

ImpediMed Director Increases Stake with New Grants

Impedimed Limited (AU:IPD) has released an update. Impedimed Limited has reported a significant change in the interests of Director Mr. McGregor Gr...

Impedimed Director Increases Stake with Options Grant

Ord Minnett analyst Tom Godfrey maintained a Buy rating on Impedimed Limited (IPDQF – Research Report) today and set a price target of A$0.13. The ...

Ord Minnett Keeps Their Buy Rating on Impedimed Limited (IPDQF)

Impedimed Limited (AU:IPD) has released an update. ImpediMed Limited, listed on the ASX under the symbol IPD, is set to present at the Wilsons Advi...

ImpediMed Limited Presents at Major Conference

In a report released on October 22, Elyse Shapiro from Canaccord Genuity maintained a Buy rating on Impedimed Limited (IPDQF – Research Report), wi...

Impedimed Limited (IPDQF) Receives a Buy from Canaccord Genuity

Impedimed Limited (AU:IPD) has released an update. Impedimed Limited has announced the issuance of 462,895 fully paid ordinary shares to executives...

Impedimed Limited Issues Shares to Executives

Impedimed Limited (AU:IPD) has released an update. ImpediMed Limited, listed on the ASX under the ticker IPD, announced its participation in the Be...

ImpediMed Limited Showcases Innovations at Bell Potter

Impedimed Limited (AU:IPD) has released an update. ImpediMed Limited's CEO is set to present at the 2024 Annual General Meeting, focusing on establ...

ImpediMed Limited Aims to Set New Standard of Care

Impedimed Limited (AU:IPD) has released an update. ImpediMed Limited is undergoing a strategic shift to focus on commercialization, aiming to trans...

ImpediMed Limited Focuses on Commercial Growth Strategy

Impedimed Limited (AU:IPD) has released an update. ImpediMed Limited successfully passed all resolutions during its Annual General Meeting, includi...

ImpediMed Limited's AGM Resolutions Signal Strategic Growth

Impedimed

Comments

Impedimed

News

Latest news for Impedimed (OTC:IPDQF) Stock

Thursday, February 27, 2020

Tuesday, February 11, 2020

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga